Research to make early detection of Alzheimer’s disease more accessible

By combining a simple blood test with a cognitive exam and demographics, researchers at UNT Health Science Center were able to accurately detect Alzheimer’s disease, even in its very early stages.

The research could lead to a rapid, accurate and cost-effective way to screen for Alzheimer’s disease, said Dr. Sid O’Bryant, Interim Director of the Institute for Aging and Alzheimer’s Disease Research and one of four authors of the study in the Journal of Alzheimer’s Disease.

"We’re talking about one finger stick and a short cognitive test," Dr. O’Bryant said.  "Every patient 60 and older could get it once a year from their primary care doctor."

For the study, only two blood biomarkers were screened. The Clock Drawing Test, which requires participants to place the hands and numbers on a predetermined time, was used for the cognitive exam.

The combination of tests could make early detection more accessible to the growing population of people at risk for Alzheimer’s disease. Currently 5.2 million people have Alzheimer’s disease, but that number is expected to triple by 2050.

The prevalence of Alzheimer’s disease has led to a heightened interest in finding an accurate tool for early detection. Earlier treatment helps preserve function and leads to better outcomes, Dr. O’Bryant said.

The model could be used to screen for the disease before more expensive, time-consuming and invasive procedures are considered.

"Instead of a comprehensive dementia exam, which takes two hours, this entire process can be done in less than 10 minutes," Dr. O’Bryant said. "Then if you get a positive result, you can do a full blown blood test and brain scan."

It also would make screening available to more people.

"The problem now is there are far more elders who should be screened for cognitive loss than there is capacity," Dr. O’Bryant said. "This is cost effective, time effective, and it won’t over-burden the health care system."

The financial burden for Alzheimer’s disease is estimated at $200 billion but that could reach $1.1 trillion by 2050.

Dr. James Hall, Professor of Psychiatry and Behavioral Health also participated in the research. Melissa Edwards, a PhD student in the psychology department at UNT was lead author on the study.

Recent News

Brock Hoffman 08
  • Community
|Nov 24, 2025

Cowboys’ Brock Hoffman honors wife’s UNT Health PA program through NFL’s ‘My Cause My Cleats’ initiative

When Dallas Cowboys offensive lineman Brock Hoffman takes the field for warm-ups before Sunday’s game against the Eagles, his cleats will carry a message far bigger than football. As part of the NFL’s annual “My Cause My Cleats” campaign, Hoffman has chosen to honor his wife, Abbey Montoy...
Ab97cf99 8f28 4b5f 8ad9 F54ee30a0022
  • Community
|Nov 14, 2025

UNT Health welcomes new research director to North Texas Eye Research Institute

A former scientific project and alliance manager at the Allen Institute for Brain Science in Seattle recently was named the new director of research for UNT Health Fort Worth’s North Texas Eye Research Institute, guiding its next phase of growth and innovation. David Vumbaco, Ph.D., started h...
Img 3423
  • Community
|Nov 14, 2025

UNT Health’s marketing and communications initiatives earn top honors at PRSA Worthy Awards

UNT Health Fort Worth’s marketing and communications staff members were recognized among the region’s best at the 2025 PRSA Worthy Awards Gala, earning multiple honors for creative storytelling and strategic impact. Presented on Nov. 7 by the Greater Fort Worth Chapter of the Public Relations S...
Img 3670
  • Community
|Nov 13, 2025

Report shows attending TCOM the most affordable in the nation

A recent report published by the American Association of Colleges of Osteopathic Medicine showed the cost of producing some of the top primary care physicians in the nation might surprise you, as UNT Health at Fort Worth’s Texas College of Osteopathic Medicine was among the most affordable in the ...